Company

Our Firm

We are constantly researching and developing to find the most sustainable method of cervical cancer screening system by Cervicography.

The Analogue Cervicography (Screening test of Cervix), which is developed in University of Wisconsin, was first adopted domestically by NTL in 1996.

Since then we have made efforts in order to drop the incidence rate of cervical cancer, and thus, it has succeed as the rate shifted from 1st place to 7th place in Korea.

However, instead of remaining with those results, NTL continued researching and developing to realize the availability of Cervicography whenever and wherever the Internet is connected.

The Analogue Cervicography (Screening test of Cervix), which is developed in University of Wisconsin, was first adopted domestically by NTL in 1996.

Since then we have made efforts in order to drop the incidence rate of cervical cancer, and thus, it has succeed as the rate shifted from 1st place to 7th place in Korea.

However, instead of remaining with those results, NTL continued researching and developing to realize the availability of Cervicography whenever and wherever the Internet is connected.

In 2003, the web-based Cervicography was developed, and in 2012, the world first wireless Cervicography was developed by NTL.

Nowadays, the Cervicography service is provided to domestic hospitals and clinics, and also those of abroad as well.

As a result, NTL could become the top cervical screening service company with systematic quality control and by integrating all the other cervical cancer screening tests domestically.

From 2008, we expanded our business to clinical laboratory test service.
We provide solution with high quality to our clients.

In accordance with our core value point, we would never hesitate to make contribution on human health and society as cultivating creative and talented people, and finally be the medical company which constantly endeavors for the improvement of public’s health and medical advance in screening test market.
In accordance with our core value point, we would never hesitate to make contribution on human health and society as cultivating creative and talented people, and finally be the medical company which constantly endeavors for the improvement of public’s health and medical advance in screening test market.

We are constantly researching and developing to find the most sustainable method of cervical cancer screening system by Cervicography.

Since 1996,
Our main playground is Obstetrics & Gynecology and we provide:

Cervicography
R&D Center

Molecular
Diagnostic Center

Diagnotic Center

Cell and Tissue
Pathology Center

Big data

6M +

Business Experience

25YRS +

Market share in Korea

70% +

Women examination
per year in Korea

500K +